Cargando…

Cancer Stem Cells of Diffuse Large B Cell Lymphoma Are Not Enriched in the CD45(+)CD19(-) cells but in the ALDH(high) Cells

Although the existence of cancer stem cells (CSCs) has been suggested in diffuse large B cell lymphoma (DLBCL), there is still no definitive marker. CD45(+)CD19(-) has been regarded as a potential marker of CSCs in mantle cell lymphoma (MCL). So, we explored the role of CD45(+)CD19(-) in DLBCL. Howe...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Shupeng, Li, Yongguo, Zhang, Kaili, Zhang, Xi, Huang, Yanxin, Xu, Mingyan, Li, Shuangxing, Guan, Xue, Yang, Tao, Liu, Zhiyu, Jiang, Jie, Luo, Yunping, Lan, Yinghua
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Ivyspring International Publisher 2020
Materias:	Research Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930399/ https://www.ncbi.nlm.nih.gov/pubmed/31892981 http://dx.doi.org/10.7150/jca.35000

Ejemplares similares

Hepatitis B Virus Replication in CD34(+) Hematopoietic Stem Cells From Umbilical Cord Blood
por: Huang, Yanxin, et al.
Publicado: (2016)

T-bet expression in CD8+ T cells associated with chronic hepatitis B virus infection
por: Fan, Rongshan, et al.
Publicado: (2016)

TNF‐α/NF‐κB signaling epigenetically represses PSD4 transcription to promote alcohol‐related hepatocellular carcinoma progression
por: Shi, Jia’ning, et al.
Publicado: (2021)

Evaluation of STAT3 Signaling in ALDH+ and ALDH+/CD44+/CD24− Subpopulations of Breast Cancer Cells
por: Lin, Li, et al.
Publicado: (2013)

Differential Expression of CD45RO and CD45RA in Bovine T Cells
por: Kandel, Anmol, et al.
Publicado: (2022)

Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2017)

Human Hepatic Progenitor Cells Express Hematopoietic Cell Markers CD45 and CD109
por: Li, Jun, et al.
Publicado: (2013)

Therapy Strategy of CD47 in Diffuse Large B-Cell Lymphoma (DLBCL)
por: Zhang, Wenqi, et al.
Publicado: (2021)

STAT3 as a potential therapeutic target in ALDH(+) and CD44(+)/CD24(+) stem cell-like pancreatic cancer cells
por: Lin, Li, et al.
Publicado: (2016)

Defining Diffuse Large B-Cell Lymphoma Immunotypes by CD8+ T Cells and Natural Killer Cells
por: Qi, Jing, et al.
Publicado: (2022)

Regulation of CD45 phosphatase by oncogenic ALK in anaplastic large cell lymphoma
por: Mura, Giulia, et al.
Publicado: (2023)

Author Correction: Unraveling the roles of CD44/CD24 and ALDH1 as cancer stem cell markers in tumorigenesis and metastasis
por: Li, Wenzhe, et al.
Publicado: (2018)

T Cell Defects: New Insights Into the Primary Resistance Factor to CD19/CD22 Cocktail CAR T-Cell Immunotherapy in Diffuse Large B-Cell Lymphoma
por: Wang, Jiachen, et al.
Publicado: (2022)

The frequency of differentiated CD3(+)CD27(-)CD28(-) T cells predicts response to CART cell therapy in diffuse large B-cell lymphoma
por: Worel, Nina, et al.
Publicado: (2023)

Tumor protein 53 mutations are enriched in diffuse large B-cell lymphoma with irregular CD19 marker expression
por: Kazantseva, Marina, et al.
Publicado: (2017)

Identifying the Therapeutic and Prognostic Role of the CD8+ T Cell-Related Gene ALDH2 in Head and Neck Squamous Cell Carcinoma
por: Zhang, Hongmei, et al.
Publicado: (2022)

Primary CNS CD45-Depleted T-Cell Lymphoma: The First Pathologically Confirmed Case
por: Morisako, Tamaki, et al.
Publicado: (2020)

CD19 directed CAR T cell therapy in diffuse large B-cell lymphoma
por: Quintás-Cardama, Alfonso
Publicado: (2018)

Leukemic Phase of CD5+ Diffuse Large B-Cell Lymphoma
por: Hsiao, Hui-Hua, et al.
Publicado: (2018)

CD19-Targeted Immunotherapies for Diffuse Large B-Cell Lymphoma
por: Gambella, Massimiliano, et al.
Publicado: (2022)

Identification of Stem-Like Cells in Atrial Myxoma by Markers CD44, CD19, and CD45
por: Song, Xianghe, et al.
Publicado: (2016)

CD4 T Cells Treated with gp120 Acquire a CD45R0+/CD45RA+ Phenotype
por: Trushin, Sergey A, et al.
Publicado: (2009)

Identification of circulating CD31(+)CD45(+) cell populations with the potential to differentiate into erythroid cells
por: Monaco, Maria Chiara G., et al.
Publicado: (2021)

Regulatory interactions between CD45RBhigh and CD45RBlow CD4+ T cells are important for the balance between protective and pathogenic cell- mediated immunity
Publicado: (1994)

CD32 is enriched on CD4(dim)CD8(bright) T cells
por: Virdi, Amber K., et al.
Publicado: (2020)

A phase 1 trial of SGN-CD70A in patients with CD70-positive diffuse large B cell lymphoma and mantle cell lymphoma
por: Phillips, Tycel, et al.
Publicado: (2018)

Coexpression of CD5 and CD43 predicts worse prognosis in diffuse large B‐cell lymphoma
por: Ma, Xiao‐bo, et al.
Publicado: (2018)

A New Strategy Using ALDH(high)-CD8+T Cells to Inhibit Tumorigenesis
por: Luo, Huiyan, et al.
Publicado: (2014)

Expression of naive/memory (CD45RA/CD45RO) markers by peripheral blood CD4(+) and CD8(+) T cells in children with asthma
por: Machura, Edyta, et al.
Publicado: (2008)

Differentiation of CD45(−)/CD31(+) lung side population cells into endothelial and smooth muscle cells in vitro
por: Xu, Yang, et al.
Publicado: (2019)

ALDH1+ stem cells demonstrate more stem cell-like characteristics than CD44(+)/CD24(–/low) stem cells in different molecular subtypes of breast cancer
por: Chen, Jie, et al.
Publicado: (2020)

CD45RA and CD45RO Are Regulated in a Cell-Type Specific Manner in Inflammation and Sepsis
por: Ahmed, Muhammad G. T., et al.
Publicado: (2023)

CD45(dim)CD34(+)CD38(−)CD133(+) cells have the potential as leukemic stem cells in acute myeloid leukemia
por: Heo, Sook-Kyoung, et al.
Publicado: (2020)

Decreased effector memory CD45RA(+ )CD62L(- )CD8(+ )T cells and increased central memory CD45RA(- )CD62L(+ )CD8(+ )T cells in peripheral blood of rheumatoid arthritis patients
por: Maldonado, Anastacia, et al.
Publicado: (2003)

Expression and prognostic value of tumor stem cell markers ALDH1 and CD133 in colorectal carcinoma
por: ZHOU, FEI, et al.
Publicado: (2014)

Primary CD20‐positive mediastinal diffuse large B‐cell lymphoma
por: Rajabto, Wulyo, et al.
Publicado: (2020)

CD4+CD45RA+ T-cells from early diffuse systemic sclerosis patients produce high levels of interleukin-17
por: van Bon, Lenny, et al.
Publicado: (2011)

Cancer stem cell markers ALDH1 and CD44+/CD24– phenotype and their prognosis impact in invasive ductal carcinoma
por: Rabinovich, Iris, et al.
Publicado: (2018)

Dual specific CD19/CD22-targeted chimeric antigen receptor T-cell therapy for refractory diffuse large B-cell lymphoma: A case report
por: Huang, Chen, et al.
Publicado: (2020)

Primary gastric natural killer/T-cell lymphoma with diffuse CD30 expression and without CD56 expression: A case report
por: ZHANG, LIZHI, et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_r0mdt4loa0pftaiqj4rs27fmlr